Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neovascular Age-related Macular Degeneration (AMD)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT04907409
What this trial is testing

Home OCT Fluid Visualization Agreement Study

Who this might be right for
Neovascular Age-related Macular Degeneration
Notal Vision Inc. 120
Early research (Phase 1)Not Yet RecruitingNCT06623279
What this trial is testing

Open-laBel Dose-escalation Study for CRISPR/cas13- Rna TargetInG THerapy for the Treatment of Neovascular Age-related Macular Degeneration in Phase I Trial

Who this might be right for
Neovascular Age-Related Macular Degeneration (nAMD)
HuidaGene Therapeutics Co., Ltd. 15
Post-approval studies (Phase 4)Study completedNCT01127360
What this trial is testing

LUCAS (Lucentis Compared to Avastin Study)

Who this might be right for
Exudative Age-related Macular Degeneration
Oslo University Hospital 420
Testing effectiveness (Phase 2)Study completedNCT02507388
What this trial is testing

Safety and Pharmacokinetics of RTH258 in Subjects With Age-Related Macular Degeneration

Who this might be right for
Neovascular Age-Related Macular Degeneration
Alcon Research 51
Post-approval studies (Phase 4)Study completedNCT02305238
What this trial is testing

Japanese Treat and Extend Study of Aflibercept in Neovascular Age-related Macular Degeneration

Who this might be right for
Wet Macular Degeneration
Bayer 288
Post-approval studies (Phase 4)Study completedNCT04679935
What this trial is testing

Efficacy and Safety of Two Different Brolucizumab 6 mg Dosing Regimens in Neovascular Age-related Macular Degeneration

Who this might be right for
Age-related Macular Degeneration
Novartis Pharmaceuticals 52
Not applicableStudy completedNCT05324150
What this trial is testing

M Charts Versus Amsler Test in Evaluating Metamorphopsia in nAMD

Who this might be right for
Macular Degeneration, WetMetamorphopsia
Ospedale Santa Croce-Carle Cuneo 57
Not applicableStudy completedNCT00460408
What this trial is testing

Ocular Safety Of Patients Receiving Macugen For Neovascular Age Related Macular Degeneration

Who this might be right for
Macular Degeneration
Pfizer 501
Testing effectiveness (Phase 2)Study completedNCT01134055
What this trial is testing

Dose Ranging Study of Pazopanib to Treat Neovascular Age-Related Macular Degeneration

Who this might be right for
Macular Degeneration
GlaxoSmithKline 510
Testing effectiveness (Phase 2)Study completedNCT00344227
What this trial is testing

Prospective OCT Study With Lucentis for Neovascular AMD (PrONTO Study)

Who this might be right for
Neovascular Age-Related Macular Degeneration
University of Miami 40
Large-scale testing (Phase 3)Study completedNCT00215670
What this trial is testing

Study of the Safety, Tolerability and Pharmacokinetics of 1 Mg/Eye and 3 Mg/Eye Pegaptanib Sodium in Patients With Exudative Age-Related Macular Degeneration (AMD)

Who this might be right for
Age-Related Macular Degeneration
Eyetech Pharmaceuticals 125
Post-approval studies (Phase 4)Study completedNCT02120950
What this trial is testing

Aflibercept in Polypoidal Choroidal Vasculopathy

Who this might be right for
Neovascular Macular Degeneration
Bayer 333
Testing effectiveness (Phase 2)Study completedNCT01849692
What this trial is testing

ESBA1008 Microvolume Study

Who this might be right for
Exudative Age-Related Macular Degeneration
Alcon Research 107
Testing effectiveness (Phase 2)Study completedNCT01414153
What this trial is testing

Efficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMD

Who this might be right for
Exudative Age-related Macular Degeneration
Lpath, Inc. 158
Not applicableLooking for participantsNCT07308639
What this trial is testing

DATA-INSIGHT is a Project That Looks at Health Data in Germany to Find Out How Many Patients Suffer From Eye Disease. The Project Also Explores New Ways to Collect and Use Publicly Available Healthcare Information.

Who this might be right for
Neovascular Age-related Macular Degeneration (nAMD), Diabetic Macular Edema (DME), Retinal Vein Occlusion (RVO)
Bayer 50,000
Not applicableEnded earlyNCT04935411
What this trial is testing

Russian Registry of Patients With nAMD

Who this might be right for
Neovascular Age-Related Macular Degeneration
Novartis Pharmaceuticals 2,665
Early research (Phase 1)Study completedNCT04989699
What this trial is testing

Study Evaluating the Treatment of OTX-TKI for Subjects With Neovascular Age-related Macular Degeneration

Who this might be right for
Neovascular Age-Related Macular Degeneration
Ocular Therapeutix, Inc. 21
Not applicableUnknownNCT01174407
What this trial is testing

Implication of CD35, CD21 and CD55 in Exudative Age-related Macular Degeneration

Who this might be right for
Age-Related Macular Degeneration
Rudolf Foundation Clinic 120
Post-approval studies (Phase 4)WithdrawnNCT04075136
What this trial is testing

Optical Coherence Tomography Angiography (OCTA) - Directed PDT Triple Therapy

Who this might be right for
Exudative Age Related Macular Degeneration
Wake Forest University Health Sciences
Large-scale testing (Phase 3)Study completedNCT04857177
What this trial is testing

Evaluate CKD-701 and Lucentis® in Patients With Neovascular(Wet) Age Related Macular Degeneration

Who this might be right for
Neovascular(Wet) Age Related Macular Degeneration
Chong Kun Dang Pharmaceutical 312
Next Page